Aspen API. More than just an API.
01 1Aspen Oss B.V.
02 3Dr.Reddy's Laboratories Limited
03 1Bayer AG
04 1SHAKTI LIFESCIENCE PRIVATE LIMITED
05 1Valdepharm
01 1NORETHINDRONE
02 1NORETHINDRONE MICRONIZED
03 1Norethindrone
04 1Norethindrone Fine Grade
05 1Norethindrone micronized
06 1Norethisterone
07 1norethisterone
01 1Germany
02 4India
03 1Luxembourg
04 1Netherlands
NDC Package Code : 60870-0235
Start Marketing Date : 1980-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 30007-829
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 30007-830
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 30007-831
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12866-1013
Start Marketing Date : 2017-05-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24823-910
Start Marketing Date : 2011-09-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73774-005
Start Marketing Date : 2022-03-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A 17.alpha.-Ethynyl-19-nortestosterone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 17.alpha.-Ethynyl-19-nortestosterone, including repackagers and relabelers. The FDA regulates 17.alpha.-Ethynyl-19-nortestosterone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 17.alpha.-Ethynyl-19-nortestosterone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 17.alpha.-Ethynyl-19-nortestosterone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 17.alpha.-Ethynyl-19-nortestosterone supplier is an individual or a company that provides 17.alpha.-Ethynyl-19-nortestosterone active pharmaceutical ingredient (API) or 17.alpha.-Ethynyl-19-nortestosterone finished formulations upon request. The 17.alpha.-Ethynyl-19-nortestosterone suppliers may include 17.alpha.-Ethynyl-19-nortestosterone API manufacturers, exporters, distributors and traders.
click here to find a list of 17.alpha.-Ethynyl-19-nortestosterone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 17.alpha.-Ethynyl-19-nortestosterone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 17.alpha.-Ethynyl-19-nortestosterone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 17.alpha.-Ethynyl-19-nortestosterone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 17.alpha.-Ethynyl-19-nortestosterone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 17.alpha.-Ethynyl-19-nortestosterone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 17.alpha.-Ethynyl-19-nortestosterone suppliers with NDC on PharmaCompass.
We have 5 companies offering 17.alpha.-Ethynyl-19-nortestosterone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?